Peer Review History
Original SubmissionSeptember 29, 2020 |
---|
PONE-D-20-30510 The role of institutional delivery and newborn care in preventing early-neonatal mortality in Bangladesh PLOS ONE Dear Dr. Ijdi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 26 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Calistus Wilunda, DrPH Academic Editor PLOS ONE Additional Editor Comments: In the abstract (and maybe elsewhere) it is not explicit who are “their counterparts”. Use multivariable instead of multivariate. To distinguish between these two terms, please refer this this https://academic.oup.com/ntr/advance-article/doi/10.1093/ntr/ntaa055/5812038 In descriptive results in the tables, clarify whether the frequencies and percentages are weighted or unweighted It is unclear whether all the survey design features, including weighting and stratification, were taken into account. P values of 0.000 should be written as <0.001 In Table 3, please present the results of the pre-specified exposure variables first. In presenting (and discussing) the results, please focus on the exposure variables of interest. This is because the multivariable model includes some variables that are on the causal pathway. For example, size of child at birth, a proxy for birthweight, is most likely a mediator between maternal socio-demographic characteristics and ENNM. Thus, the ORs for the socio-demographic characteristics may be biased. Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. In statistical methods, please clarify whether you corrected for multiple comparisons. 3. In your statistical analyses, please state whether you accounted for clustering by region/ state. For example, did you consider using multilevel models? If not, please provide your rationale for not doing so. 4. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. 5. We note that Figure 1 in your submission contain map images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright. We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission: 5.1. You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license. We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text: “I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.” Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission. In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].” 5.2. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only. The following resources for replacing copyrighted map figures may be helpful: USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/ The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/ Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/ Landsat: http://landsat.visibleearth.nasa.gov/ USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/# Natural Earth (public domain): http://www.naturalearthdata.com/ [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Comments are given in the manuscript Comments are given in the manuscript. Comments are given in the manuscriptComments are given in the manuscriptComments are given in the manuscriptComments are given in the manuscriptComments are given in the manuscript Reviewer #2: PONE-D-20-30510 The role of institutional delivery and newborn care in preventing early-neonatal mortality in Bangladesh The study has several strengths and significant implications, but these were not highlighted in the manuscript. There are many key issues. Please see below for details. Major comments 1. The abstract reflects the title, but not the manuscript. The authors could structure the article based on the title and the abstract. Exploring a single exposure-outcome relationship could be more interesting than exploring (many) factors associated with the outcome. 2. The rationale of the study idea is vague. The authors claimed that only a few studies had been done, and most of them are small-scale and clinically oriented. What is the problem of clinically-oriented studies? Ref 17 used BDHS 2011, Ref 19 used 15 times larger sample size than this study, Ref 26 had results from cluster randomized controlled trials, and Ref 27 used BDHS 2004, 2007, and 2011 (and they had approximately four times larger sample size than this study). 3. The study objective is ambiguous. The title says the authors explored the relationship of institutional delivery and newborn care with early neonatal mortality in Bangladesh. But Page 5 (line 4) says differently. The authors even confuse the readers on Page 5 (line 7) and Page 6 (line 4-5). This confusion remained a significant issue throughout the manuscript. However, having a single objective, e.g., exploring the relationship between institutional delivery and early neonatal mortality, could be more interesting. 4. The introduction is unnecessarily big. This section could have only a maximum of 10–15% of the manuscript’s total word count (https://doi.org/10.1016/j.jclinepi.2013.01.004). 5. To provide the scientific community with novel results, the authors could redo the study with more recent survey data (e.g., BDHS 2017-18). 6. The conceptual framework is incomplete. The authors missed many relevant covariates, e.g., maternal BMI, occupation, birth order, birth interval, previous death of any siblings, number of ANC, type of delivery, paternal education and occupation, etc. (https://doi.org/10.1371/journal.pone.0221503; https://bmjopen.bmj.com/content/5/8/e006722; https://archpublichealth.biomedcentral.com/articles/10.1186/s13690-017-0224-6). Please include all relevant covariates or use stepwise with AIC in the model building. However, the better option is to use a directed acyclic graph to identify potential confounders and risk factors (https://www.nature.com/articles/s41390-018-0071-3; https://link.springer.com/article/10.1007%2Fs10654-019-00494-6). 7. Page 6, line 4-12: The hypothesis part should be in the Introduction section (just after the study aim) instead of the Methods. 8. The methods used are technically incorrect. The authors must use the design-based Rao-Scott test instead of Pearson’s Chi-square test to account for the complex survey design. Also, the authors only considered sampling weights in the regression analysis. But they did not consider all the complex survey design-features (e.g., strata, cluster, sampling weights). 9. Model diagnostics are missing. Also, model validation or sensitivity analysis is missing. The authors could use the generalized estimating equation (GEE) or propensity score matching/weighting as a sensitivity analysis for the main findings. 10. The analysis strategies are mostly not understandable and reproducible. Also, all the methods were not introduced or at least mentioned/cited in the Methods section before discussing them in the Results/Discussion section. 11. Tables should be stand-alone so that readers can understand a table without reading the text and vice versa. 12. The results interpretation both in the Result section and Discussion section is somewhat poor. There is too much description of confounded results (Table 1 to 3). Page 10 (line 8-17): wrong interpretation. Trend analysis is not possible from this study, but the authors interpreted it as “increases/decreases.” This should be “higher/lower.” 13. Table 4 is very interesting. But the interpretation of the results is not adequate. There is Table 2 fallacy (https://doi.org/10.1093/aje/kws412). 14. The first paragraph of the Discussion section does not match with the Result section. Overall, the logical integration of concepts (from introduction to discussion) needs to be improved. The authors should concisely write the paper. There are many irrelevant discussions throughout the manuscript. In contrast, the study implications and future directions are missing. The rate of the quality of contribution in the literature and strong implications are not adequate. Also, the study strength is not well articulated. Minor changes 15. The outcome is extremely rare (the prevalence is ~1.4%). The authors could aggregate two/three cycles to improve statistical power. 16. Need references in categorizing many of the covariates, particularly when constructing them. Otherwise, please provide validation of these constructions. 17. Page 2, line 2-3: Paraphrase the line. The line is just a copy from the cited article. 18. Figure 1: Not sure why needed. The authors could drop this figure. 19. Page 3, line 9-11:” Update the statistics based on BDHS 2017-18. 20. Multicollinearity is not a major problem in causal models. Instead, we want to reduce confounding bias regardless of collinear variables. 21. Table 1: Some % do not add up to 100%. 22. Tables and figures could be improved. The figure's quality is too low, and the tables are not of publication quality. Please drop vertical lines and put only 3/4 horizontal lines based on the objective for each table. 23. Page 13, line 4: The odds of ENNM was… 24. Page 14, line 2: … significantly associated with ENN (or significantly associated with lower odds of ENNM). 25. Put total/overall just after the heading of the table, not at the bottom. 26. Drop stars from the tables. The authors have used p-values in three decimal points. Please use <0.001 if any p-value is less than 0.001. 27. Add a limitation: The temporality of the association cannot be made due to the nature of the study design. Reviewer #3: The manuscript deals with identifying the factors affecting early neonatal mortality (ENNM), which represents more than 80\\% of all neonatal mortality in Bangladesh, with a specific focus on place of delivery and newborn care. The 2014 Bangladesh Demographic and Health Survey data were used for assessing early-neonatal survival in children born in the three years preceding the survey. Multivariate logistic regression models have been used. The study findings highlight the importance of newborn and postnatal care in preventing early neonatal deaths. I suggest some revisions. Following questions must be needed to answer. 1. Any variables about husband have not been used. Particularly, husband's education, or parental education, employment status, occupation are important to consider. Besides, mother's age at first birth is important. 2.Why 2018 BDHS data has not been used for this study instead of BDHS 2014 data? 3. How about the death rate among the missing cases? Total 309 cases have been omitted. Just in case if considerable amount of death rate is found among 309 cases, then suitable imputation method could be used to impute the missing observations. 4. Have the twin babies considered here. If so then, whether it could be an important factor in the model. 5. In Statistical Analysis section, Variance inflation factors (VIF) were assessed to examine collinearity between variables before entering them into the multivariable models? What cut off point was used here? 6. The confounding could be existed here. Particularly, ANC visits and ENNM might be under important consideration in making such unobserved confounding. What is the response of authors in this regards? 7. Is simple map as displayed in Figure 1 important? Rather authors could have mapping for Bangladesh by disagegating to division levels. Authors could use many software including ``mapReasy" R package (Islam et al., 2017). ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Md. Belal Hossain Reviewer #3: Yes: Md Hasinur Rahaman Khan [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
Revision 1 |
PONE-D-20-30510R1 The role of institutional delivery and newborn care in preventing early-neonatal mortality in Bangladesh PLOS ONE Dear Dr. Ijdi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Reviewers have raised valid concerns regarding data analysis and the dataset analyzed. Please consider analyzing the latest DHS data to provide the most updated information. Please submit your revised manuscript by Aug 27 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Calistus Wilunda, DrPH Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. No COmment Reviewer #2: I'm repeating my comments that I submitted as an attachment: The authors have made some significant changes. However, there are still many major issues that need to be addressed: 1. In response to aggregating 2/3 cycles of data to improve statistical power, the authors mentioned that the proportion of women delivering in health facilities has been increasing over time, affecting the relationship between delivery care and early neonatal mortality. If this is true, why would we believe findings from BDHS 2014 data would reflect the current scenario of the association? The BDHS 2017-18 dataset is already publicly available, and it should only take a couple of days to access the dataset. Then why would be we believe BDHS 2014 dataset is more likely to reflect the current scenario than BDHS 2017-18? In Table 4 (model 3), the authors adjusted the model for many covariates. However, the number of events is only 69 in the study (Table 1). For example, there are only 69/29 ≈ 2 events per effective degrees of freedom. Therefore, the estimates from the current models could be unstable and invalid as per the events per variable (EPV) rule (https://doi.org/10.1016/0895-4356(95)00510-2; https://link.springer.com/article/10.1007/s10985-013-9290-4#ref-CR15; https://doi.org/10.1093/aje/kwk052). In the previous version, it was recommended to use an alternative method (e.g., propensity score full-matching, propensity score weighting) as a sensitivity analysis for the main findings. Since there are very few events and only 2 events per effective degrees of freedom (i.e., 2 EPV), why should we rely only on the logistic regression results? The odds ratio from the logistic regression also often suffers from many major problems (e.g., non-collapsible bias; https://doi.org/10.1177%2F0962280213505804). The authors should provide a strong rationale why they are insisted (i) using the BDHS 2014 dataset but not the BDHS 2017-18 dataset, (ii) relying only on results from a single model instead of sensitivity analysis of the main findings using an alternative model, and (iii) why EPV is not a major concern, or if EPV is a concern why not they consider multiple cycles to improve statistical power and stability of the model. 2. According to Annex 1, PNC and ENC are mediators in the relationship between place of delivery (exposure) and early neonatal mortality (outcome). Adjusting for a mediator leads to decompose the total effect into direct and indirect effects (https://doi.org/10.1093/ije/dyt127). Therefore, the authors should not adjust for PNC and ENC in the same model when exploring the total effect of delivery place on early neonatal mortality. To explore the effect of PNC and ENC on early neonatal mortality, they should run a separate model. There are some minor issues as well: 1. The title needs to be changed. Considering the study design of BDHS, one can only explore the association of institutional delivery and newborn care with early-neonatal mortality. We need longitudinal studies to conclude whether institutional delivery and newborn care actually prevent early neonatal deaths. One example revised title is “Exploring the association of the place of delivery and newborn care with early-neonatal mortality in Bangladesh”. Otherwise, please justify why the term “preventing early-neonatal mortality” is appropriate in the title. 2. The study objective in the Introduction is written as “This study aims to explore the association of the place of delivery and newborn care with ENNM in Bangladesh.” However, the aim is different in the Abstract. Please restate and clearly specify the study objective in the Abstract. 3. Pleased drop the sentence from the abstract “Singleton births had 95% lower odds of dying in the first seven days of life compared to twin birth (aOR: 0.05; 95% CI: 0.01-0.16) in the same period.” This result is not aligned with the study’s objective. Instead, it is the Table 2 fallacy. 4. The conclusion in the Abstract is wrong. Since delivery at the health facility is not associated with early neonatal deaths, how the study findings highlight the importance of newborn and postnatal care in preventing early neonatal deaths? Please clarify. 5. The study’s strength “The sample size is also relatively large …” is not true. Considering the extremely rare event, the study’s sample size ~4000 is tiny (http://www.vanbelle.org/chapters/webchapter2.pdf; https://doi.org/10.1016/0047-2352(86)90111-X). The authors should restate the argument or provide the rationale for using this as a strength. Reviewer #3: I have gone through the revised manuscript and found insufficient responses to some vital points. Hence, still following questions must be responded properly to improve this manuscript. 1. Authors need to give more strong reference against their claim ``Based on best practice, our preference is to include only the minimally sufficient adjustment set" as mentioned in the answer of first point. Many studies found direct associations of parental education, employment status, occupation with neo-natal mortality. Otherwise, they need to carry out the analysis with these variables in the model. 2. The data of BDHS2018 is available and all the variable codes are same as BDHS2014. Authors must need to redo all analyses with this data. Authors mentioned that they will do the same analysis and make another paper which is pointless as the dataset is already available. 3. Authors did not mention whether there was no any missingness in the covariates considered apart from answering missingness among the discarded 309 cases. 4. Figure 1 in previous manuscript was suggested to revise by using MapReasy which is important to strengthen this manuscript but authors omitted this. Authors need to generate and include such graph. 5. Authors still mentioned in abstract and statistical analysis section that multivaiate logistic..... It should be multivaiable logistic.... 6. Some references are missing pages, volume, series etc. E.g., references 18, 36, 41, 43. 7. Study strengths were unnecessarily been mentioned in the last section. Only limitations are OK. 8. Page 6, l12: DAG has been created and a minimally sufficient adjustment is set according to ref 27. There are many published well known studies but authors cited ref 27 which is not a published paper and not worthy. Here how had DAG been created? 9. Data source is insufficiently discussed. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
Revision 2 |
Exploring association between place of delivery and newborn care with early-neonatal mortality in Bangladesh PONE-D-20-30510R2 Dear Dr. Ijdi, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Calistus Wilunda, DrPH Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: revision: Similar research has been published: "Effect of antenatal care and social wellbeing on early neonatal mortality in Bangladesh" using MICS data. this findings may be compare in the discussion section Reviewer #2: The authors addressed most of the comments I had. I had no more comments except for the sensitivity analysis for the main findings. As explained in the previous version, the statistical power and stability of the model can be problematic. The reason is obvious since there are only 2 EPV. Otherwise, the paper is in good shape and can be accepted for publication. Congratulations to the authors! ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No |
Formally Accepted |
PONE-D-20-30510R2 Exploring association between place of delivery and newborn care with early-neonatal mortality in Bangladesh Dear Dr. Ijdi: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Calistus Wilunda Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .